Search details
1.
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Breast Cancer Res Treat
; 2024 May 04.
Article
in English
| MEDLINE | ID: mdl-38703285
2.
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice.
Support Care Cancer
; 29(8): 4673-4681, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33506273
3.
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.
J Cancer Res Clin Oncol
; 149(7): 2855-2882, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-35790560
4.
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.
Clin Cancer Res
; 24(23): 5820-5829, 2018 12 01.
Article
in English
| MEDLINE | ID: mdl-30061361
5.
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts.
Clin Cancer Res
; 23(3): 649-657, 2017 Feb 01.
Article
in English
| MEDLINE | ID: mdl-27301700
6.
Tratamiento del paciente con carcinoma de próstata en progresión bioquímica resistente a castración / Treatment of the patient with castration-resistant biochemical progression of prostate cancer
Arch. esp. urol. (Ed. impr.)
; 65(1): 185-192, ene.-feb. 2012. tab, graf
Article
in Spanish
| IBECS (Spain) | ID: ibc-101167
Results
1 -
6
de 6
1
Next >
>>